Pulmonary signal-intensity is reproducible and related to tissue density. In COPD subjects with and without bronchiectasis, signal-intensity was also related to pulmonary function and CT measurements.
We present a quantitative validation study to assess the accuracy of low-frequency conductivity imaging methods, based on a testing current measured using Current Density Imaging (CDI). We tested the proposed procedure to study the influence of tissue anisotropy on the accuracy of conductivity reconstruction methods, using a finite element model of anisotropic brain tissue. Simulations were carried out for three different levels of tissue anisotropy to compare the results obtained by our recently developed anisotropic conductivity method with those obtained by our well-established conductivity method that assumes isotropic conductivity. The validation results clearly show that the conductivity imaging method which takes into account tissue anisotropy yields significantly superior accuracy.
Congenital lobar emphysema is mainly diagnosed in infants, although rare cases are reported in adults. A 20-yr-old female with acute dyspnea, chest pain and left upper lobe (LUL) chest x-ray hyperlucency underwent 3He magnetic resonance imaging (MRI) for ventilation and apparent diffusion coefficient (ADC) measurements, as well as CT for emphysema and airway wall measurements. Forced expiratory volume in 1s, residual volume, and airways-resistance were abnormal, but there was normal carbon-monoxide-diffusing-capacity. The LUL relative area of the density histogram <-950 HU and airway morphology were highly abnormal compared with the other lobes and coincident with highly abnormal MRI-derived acinar duct dimensions. CT also identified bronchial atresia and congenital lobar emphysema as the source of symptoms in this case where there was also functional imaging evidence of collateral ventilation from the fissure (and not the abnormally terminated airway) into the emphysematous LUL.
This paper presents the first experiment of imaging anisotropic impedance using a novel technique called Diffusion Tensor Current Density Impedance Imaging (DTCD-II). A biological anisotropic tissue phantom was constructed and an experimental implementation of the new method was performed. The results show that DT-CD-II is an effective way of non-invasively measuring anisotropic conductivity in biological media. The cross-property factor between the diffusion tensor and the conductivity tensor has been carefully determined from the experimental data, and shown to be spatially inhomogeneous. The results show that this novel imaging approach has the potential to provide valuable new information on tissue properties.
Current density imaging (CDI) is a magnetic resonance imaging (MRI) technique used to quantitatively measure current density vectors throughout the volume of an object/subject placed in the MRI system. Electrical current pulses are applied externally to the object/subject and are synchronized with the MRI sequence. In this work, CDI is used to measure average current density magnitude in the torso region of an in-vivo piglet for applied current pulse amplitudes ranging from 10 mA to 110 mA. The relationship between applied current amplitude and current density magnitude is linear in simple electronic elements such as wires and resistors; however, this relationship may not be linear in living tissue. An understanding of this relationship is useful for research in defibrillation, human electro-muscular incapacitation (e.g. TASER(R)) and other bioelectric stimulation devices. This work will show that the current amplitude to current density magnitude relationship is slightly nonlinear in living tissue in the range of 10 mA to 110 mA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.